← Back to Search

Treatment Access Strategies for Cervical Cancer in Botswana

N/A

Recruiting

Led By Surbhi Grover, MD, MPH

Research Sponsored by Abramson Cancer Center at Penn Medicine

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up within 90 days of randomization

Awards & highlights

No Placebo-Only Group

Summary

This trial will test ways to help people in Botswana get the cervical cancer treatment they need on time.

Who is the study for?

This trial is for biological females aged 18 or older in Botswana who have been diagnosed with invasive cervical cancer confirmed by pathology. Participants must have their pathology results evaluated at the National Health Laboratory in Botswana.

What is being tested?

The study is examining four strategies to improve the timeliness of cervical cancer treatment adoption: Low-Touch Strategy, Clinic Outreach, Enhanced Outreach, and High-Touch Strategy. The effectiveness of these approaches will be compared using a practical trial design.

What are the potential side effects?

As this trial focuses on strategies to encourage treatment rather than direct medical interventions, specific side effects are not detailed. However, participants may experience varying levels of healthcare engagement based on the strategy applied.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ within 90 days of randomization

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~within 90 days of randomization

This trial's timeline: 3 weeks for screening, Varies for treatment, and within 90 days of randomization for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Adoption

Secondary study objectives

Fidelity

Reach: First Appointment

Reach: First Stage

+2 more

Other study objectives

Clinical Outcomes: Survival

Clinical Outcomes: Treatment

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

4Treatment groups

Experimental Treatment

Group I: Stage 1 Enhanced Outreach + Stage 2 Low-TouchExperimental Treatment2 Interventions

All participants receive direct clinic outreach plus enhanced outreach to communicate readiness of results (stage 1). Participants who do not attend the clinic by 30 days (non-responders) will receive asynchronous text message reminders using framed messaging (stage 2).

Group II: Stage 1 Enhanced Outreach + Stage 2 High-TouchExperimental Treatment2 Interventions

Group III: Stage 1 Clinic Outreach + Stage 2 Low TouchExperimental Treatment2 Interventions

All participants receive direct clinic outreach to communicate readiness of results (stage 1). Participants who do not attend the clinic by 30 days (non-responders) will receive asynchronous text message reminders using framed messaging (stage 2).

Group IV: Stage 1 Clinic Outreach + Stage 2 High TouchExperimental Treatment2 Interventions

Do I qualify?Apply below to find out